Thyrocare Technologies Ltd recommends final dividend of Rs 7.00 per share for FY26
Thyrocare Technologies Ltd has recommended a final dividend of Rs. 7.00 per equity share for FY26, payable to shareholders on the record date of June 23, 2026. The company detailed the Tax Deduction at Source (TDS) provisions, stating a 10% rate for resident shareholders with valid PAN and 20% for non-residents, with exemptions available for specific entities and forms. Shareholders must submit necessary documentation by June 26, 2026, to ensure appropriate tax deduction.
*this image is generated using AI for illustrative purposes only.
Thyrocare Technologies Limited has recommended a final dividend of Rs. 7.00 per equity share for the financial year ended March 31, 2026. The dividend is payable to shareholders whose names appear in the Register of Members on the record date of Tuesday, June 23, 2026, subject to shareholder approval at the Annual General Meeting on June 30, 2026. This final dividend is in addition to the interim dividend of Rs. 7.00 per share declared on October 14, 2025.
Under the Income Tax Act, 2025, the company is required to deduct tax at source at applicable rates. For resident shareholders with a valid PAN, the TDS rate is 10%. However, TDS will not apply if the aggregate dividend distributed to a resident individual during the Tax Year 2026-27 does not exceed Rs. 10,000. A higher rate of 20% applies if the PAN is invalid, inoperative, or not linked with Aadhaar.
Shareholders can avail of lower or nil TDS by submitting specific forms. Residents may submit Form 121 or a certificate under Section 395(1) of the Act. Exempt entities such as insurance companies, mutual funds, and Alternative Investment Funds (AIFs) must provide self-declarations and registration certificates issued by respective regulators like IRDAI and SEBI.
For non-resident shareholders, the standard TDS rate is 20% plus applicable surcharge and cess. Those seeking benefits under Double Tax Avoidance Agreements (DTAA) must provide a Tax Residency Certificate, PAN details, and a self-declaration meeting treaty eligibility requirements. The company emphasized it is not obligated to apply beneficial DTAA rates without satisfactory documentation.
Shareholders must submit the necessary documents to determine the appropriate tax rate by 6:00 P.M. on Friday, June 26, 2026. Documents can be emailed to compliance@thyrocare.com or uploaded via the RTA MUFG Intime India Private Limited service request portal. No claims for tax adjustments will be entertained after this deadline.
TDS Rates for Resident Shareholders
| Category | Applicable Rate | Key Requirement |
|---|---|---|
| With PAN | 10% | PAN updated with depositories or RTA |
| Without PAN / Invalid PAN | 20% | Correct PAN must be submitted to RTA |
| Submitting Form 121 | NIL | Duly verified Form 121 and PAN copy |
| Exempt Institutions (e.g., Mutual Funds) | NIL | Self-declaration and SEBI/IRDAI certificate |
TDS Rates for Non-Resident Shareholders
| Category | Applicable Rate | Key Requirement |
|---|---|---|
| FII / FPI | 20% + surcharge + cess | Self-attested SEBI registration certificate |
| Other Non-residents | 20% + surcharge + cess | PAN and residential status update |
| DTAA Benefit | Tax Treaty Rate | TRC, PAN, Form 41, and self-declaration |
Historical Stock Returns for Thyrocare Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.07% | -2.69% | +7.33% | +20.00% | +64.59% | +24.19% |
How will the total dividend payout of Rs. 14 per share impact Thyrocare’s cash flow and capital allocation plans for FY2027?
What are the expectations for Thyrocare’s dividend policy in future fiscal years given the consistent payouts in 2026?
How might the new TDS regulations under the Income Tax Act, 2025, affect shareholder participation and retention rates?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
